User profiles for Chiara Cosma

Chiara Cosma

Verified email at aopd.veneto.it
Cited by 2629

IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study

…, L Sciacovelli, D Basso, D Negrini, S Zuin, C Cosma… - Clinica chimica acta, 2020 - Elsevier
Validation studies of serological antibody tests must be properly designed for clinical,
epidemiological and Public Health objectives such as confirmation of suspected COVID-19 cases, …

[HTML][HTML] Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics

A Padoan, C Cosma, L Sciacovelli… - Clinical Chemistry and …, 2020 - degruyter.com
Background Coronavirus disease 2019, abbreviated to COVID-19, represents an emerging
health threat worldwide as, after initial reports in China, it has continued to spread rapidly. …

[HTML][HTML] Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity

…, A Bortolami, D Negrini, S Zuin, D Bozzato, C Cosma… - …, 2020 - thelancet.com
Background Reliable high-throughput serological assays for SARS-CoV-2 antibodies are
urgently needed for the effective containment of the COVID-19 pandemic, as it is of crucial …

Long-term immune response to SARS-CoV-2 infection among children and adults after mild infection

C Di Chiara, A Cantarutti, P Costenaro… - JAMA network …, 2022 - jamanetwork.com
Importance Understanding the long-term immune response against SARS-CoV-2 infection
in children is crucial to optimize vaccination strategies. Although it is known that SARS-CoV-2 …

Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers

…, L Dall'Olmo, F Della Rocca, F Barbaro, C Cosma… - Clinica chimica acta, 2021 - Elsevier
Background Vaccine-induced population immunity is a key global strategy to control coronavirus
disease 2019 (COVID-19). The rapid implementation and availability of several COVID-…

Presepsin in risk stratification of SARS-CoV-2 patients

M Zaninotto, MM Mion, C Cosma, D Rinaldi… - Clinica chimica acta, 2020 - Elsevier
Background A severe form of pneumonia, is the leading complication of the respiratory
Coronavirus disease 2019 (COVID-19), recently renamed SARS-CoV-2. Soluble cluster of …

Mild SARS-CoV-2 infections and neutralizing antibody titers

F Bonfante, P Costenaro, A Cantarutti, C Di Chiara… - …, 2021 - publications.aap.org
BACKGROUND Recent evidence suggests that neutralizing antibodies (nAbs) to severe acute
respiratory syndrome coronavirus 2 may persist over time; however, knowledge regarding …

[HTML][HTML] Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers

…, F Bonfante, C Cosma, C Di Chiara… - Clinical Chemistry and …, 2021 - degruyter.com
Objectives SARS-CoV-2 serology presents an important role in several aspects of COVID-19
pandemic. Immunoassays performances have to be accurately evaluated and correlated …

Salivary SARS-CoV-2 antigen rapid detection: a prospective cohort study

D Basso, A Aita, A Padoan, C Cosma, F Navaglia… - Clinica chimica acta, 2021 - Elsevier
Background and aim SARS-CoV-2 quick testing is relevant for the containment of new
pandemic waves. Antigen testing in self-collected saliva might be useful. We compared salivary …

The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing

…, E Boscaro, E Pagnin, E Iori, C Cosma… - Diabetes, 2010 - Am Diabetes Assoc
OBJECTIVE The redox enzyme p66Shc produces hydrogen peroxide and triggers proapoptotic
signals. Genetic deletion of p66Shc prolongs life span and protects against oxidative …